Adrian Gottschalk

Insider Reports History

Entity
Individual
Location
100 Binney Street, Suite 610, Cambridge, MA
Signature
/s /Tara Maduri, Attorney-in-Fact for Adrian Gottschalk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adrian Gottschalk:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Executive Officer, Director Common Stock 512K $4.22M $8.25 Aug 17, 2023 Indirect
Foghorn Therapeutics Inc. Chief Executive Officer, Director Stock Option (right to buy) 300K $918K $3.06 Jan 24, 2024 Direct
Foghorn Therapeutics Inc. Chief Executive Officer, Director Common Stock 0 $8.25 Aug 17, 2023 Direct

Insider Reports Filed by Adrian Gottschalk

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Jan 24, 2024 1 $918K 4 Jan 25, 2024 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. Aug 17, 2023 2 $0 4 Aug 18, 2023 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. May 26, 2023 2 $0 4 May 31, 2023 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. Sep 16, 2022 2 $21.6K 4 Sep 19, 2022 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. Feb 10, 2022 8 $0 4 Feb 22, 2023 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Executive Officer, Director
FHTX Foghorn Therapeutics Inc. Aug 20, 2021 2 $12.4K 4 Aug 23, 2021 Chief Executive Officer, Director